National Research (National Research) Cash And Cash Equivalents : $6.7 Mil (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is National Research Cash And Cash Equivalents?

National Research's quarterly cash and cash equivalents declined from Jun. 2023 ($22.50 Mil) to Sep. 2023 ($3.83 Mil) but then increased from Sep. 2023 ($3.83 Mil) to Dec. 2023 ($6.65 Mil).

National Research's annual cash and cash equivalents declined from Dec. 2021 ($54.36 Mil) to Dec. 2022 ($25.03 Mil) and declined from Dec. 2022 ($25.03 Mil) to Dec. 2023 ($6.65 Mil).

National Research Cash And Cash Equivalents Historical Data

The historical data trend for National Research's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research Cash And Cash Equivalents Chart

National Research Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

13.52

34.69

54.36

25.03

6.65

National Research Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															25.03	23.72	22.50	3.83	6.65

National Research Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

National Research (NAS:NRC) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

National Research Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of National Research's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

National Research (National Research) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » National Research Corp (NAS:NRC) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

1245 Q Street, Lincoln, NE, USA, 68508

Website

https://www.nrchealth.com

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the United States and Canada, of which key revenue is derived from the United States.

Executives

Amandla Mk Trust	10 percent owner	C/O THE BRYN MAWR TRUST COMPANY OF DELAW, 20 MONTCHANIN RD, SUITE 100, GREENVILLE DE 19807
Common Property Trust	10 percent owner	709 PIER 2, LINCOLN NE 68528
Parul Bhandari	director	1775 I STREET NW, SUITE 910, WASHINGTON DC 20006
Stephen H Lockhart	director	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Penny Ann Wheeler	director	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Donald M Berwick	director	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Jona S Raasch	officer: Vice President and COO
Kevin R Karas	officer: SVP Finance, CFO, Treas & Secy	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009	10 percent owner	C/O BESSEMER TRUST COMPANY OF DELAWARE, 1007 N. ORANGE ST., SUITE 1450, WILMINGTON DE 19801
Joann M Martin	director	6221 ANDREW COURT, LINCOLN NE 68512
Helen Hrdy	officer: Chief Growth Officer	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Steven D. Jackson	officer: President	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
John N Nunnelly	director	P.O. BOX 2175, AMHERST MA 01004
Barbara Mowry	director	P.O. BOX 103115, DENVER CO 80250
Michael Hays	director, 10 percent owner, officer: President and CEO	C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508